An 19F Magnetic Resonance–Based In Vivo Assay of Solid Tumor Methotrexate Resistance: Proof of Principle

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Cancer Research

• Publication date

  2005-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1158/1078-0432.CCR-04-1439PMID 15746046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma

  2004cited by this paper
• Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue

  2004cited by this paper
• Multivoxel magnetic resonance spectroscopy of brain tumors.

  2003cited by this paper
• Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.

  2003cited by this paper
• A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: synthesis, in vitro cytotoxicity, and pilot in vivo 19F magnetic resonance spectra.

  2003influential reference
• In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.

  2003cited by this paper
• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  2003cited by this paper
• Optimized pulse parameters for reducing quantitation errors due to saturation factor changes in magnetic resonance spectroscopy.

  2002cited by this paper
• Bayesian Estimation of Methotrexate Pharmacokinetic Parameters and Area Under the Curve in Children and Young Adults with Localised Osteosarcoma

  2002cited by this paper
• Java-based graphical user interface for the MRUI quantitation package

  2001cited by this paper
• Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.

  2001cited by this paper
• Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.

  2000cited by this paper
• A quantitative assessment of liver metabolites during jaundice using three dimensional phosphorus chemical shift imaging.

  2000cited by this paper
• Mechanisms of methotrexate resistance in osteosarcoma.

  1999cited by this paper
• On the role of MRS in drug development

  1999cited by this paper
• Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.

  1999cited by this paper
• Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity

  1998cited by this paper
• Non‐invasive 19F‐NMRS of 5‐fluorouracil in pharmacokinetics and pharmacodynamic studies

  1998cited by this paper
• Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.

  1997cited by this paper
• Simultaneous 3D NMR spectroscopy of proton‐decoupled fluorine and phosphorus in human liver during 5‐fluorouracil chemotherapy

  1997cited by this paper
• Proton‐decoupled 19F spectroscopy of 5‐FU catabolites in human liver

  1997cited by this paper
• Clinical MR Spectroscopy: First Principles

  1997cited by this paper
• Concepts in use of high-dose methotrexate therapy.

  1996cited by this paper
• Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.

  1996cited by this paper
• Intrinsic and acquired resistance to methotrexate in acute leukemia.

  1996cited by this paper
• A comparison of models for calculating nuclear magnetic resonance shielding tensors

  1996cited by this paper
• Establishment, characterization and drug sensitivity of four new human soft tissue sarcoma cell lines

  1996cited by this paper
• Evaluating 19F Chemical Shielding in Fluorobenzenes: Implications for Chemical Shifts in Proteins

  1994cited by this paper
• Association of intratumoral pharmacokinetics of fluorouracil with clinical response.

  1994cited by this paper
• Use of locally dense basis sets for nuclear magnetic resonance shielding calculations

  1993cited by this paper
• Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.

  1993cited by this paper
• Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers

  1993cited by this paper
• Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines.

  1992influential reference
• Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemia.

  1990cited by this paper
• Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

  1988cited by this paper
• Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy.

  1987cited by this paper
• Extremity bone tumors: evaluation by P-31 MR spectroscopy.

  1985cited by this paper
• Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.

  1985cited by this paper
• Signal-to-noise optimization and observed volume localization with circular surface coils

  1984cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• Cancer: Principles and Practice of Oncology

  1982cited by this paper
• Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.

  1982cited by this paper
• Mapping of metabolites in whole animals by 31P NMR using surface coils

  1980cited by this paper
• Presence of 2,4‐diamino‐N10‐methylpteroic acid after high‐dose methotrexate

  1979cited by this paper
• Selection of optimum parameters for pulse Fourier transform nuclear magnetic resonance

  1979cited by this paper
• Methotrexate tissue distribution: prediction by a mathematical model.

  1971cited by this paper
• On the nature of permeability of sarcoma-180 cells to amethopterin in vitro.

  1965cited by this paper

• The use of 19F in Medicine in Poland and in the World

  2021cites this paper
• Fluorine-19 Magnetic Resonance Angiography of the Mouse

  2012cites this paper
• Correction: Fluorine-19 Magnetic Resonance Angiography of the Mouse

  2012cites this paper
• Non‐Invasive Physiology and Pharmacology Using 19F Magnetic Resonance

  2008cites this paper
• Fluorine magnetic resonance in vivo: a powerful tool in the study of drug distribution and metabolism.

  2008cites this paper
• VatuximabTM: Optimizing Therapeutic Strategies for Prostate Cancer Based on Dynamic MR Tumor Oximetry

  2007cites this paper
• Structural Studies of Bcl-xL/ligand Complexes using 19F NMR

  2006cites this paper
• Current Awareness in NMR in Biomedicine

  2005cites this paper